Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06007404 · ClinicalTrials.gov registry record
Understanding Metabolism and Inflammation Risks for Diabetes in Adolescents
A clinical trial of Obesity and Type 2 Diabetes, sponsored by University of Michigan.
- Recruiting
- Registry status
- 175
- Enrollment target
- 1
- Study location
NCT06007404 is a study of Obesity and Type 2 Diabetes that is actively recruiting participants, run by University of Michigan. The registered enrollment target is 175 participants, below the 819-participant average among 1,053 other Obesity trials with a reported enrollment target (79% lower). The trial reports 1 study location across 1 state.
The verdict
NCT06007404, a study of Obesity and Type 2 Diabetes, is actively recruiting participants, sponsored by University of Michigan.
- RECRUITING
- Registry status
- 175 participants
- Enrollment target
- 1
- Study location
Study Summary
This research study collects health-related information and blood samples to better understand how body composition, lifestyle habits, and diet influence meta-inflammatory monocytes (MiMos) in adolescents. The hypothesis of this study is that adolescents at risk for metabolic disease have enhanced MiMo related activities leading to insulin resistance.
Conditions Studied
Study Locations (1)
Michigan
- University of Michigan - Ann Arbor
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 175 participants |
| Start Date | 2023-09-06 |
| Est. Completion | 2027-09 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT06007404
The ClinicalTrials.gov registry entry for NCT06007404 describes a study currently listed as recruiting, categorized as an unspecified phase. The registered enrollment target is 175 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 819-participant average among 1,053 other Obesity trials with a reported enrollment target (79% lower). The listed sponsor is University of Michigan, which has 1,327 total studies on file at ClinicalTrials.gov.
The record links to 5 conditions, with Obesity appearing as the primary indexed condition, and to 0 interventions.
NCT06007404 reports 1 study location spanning 1 distinct geographic area - top geographies include Michigan.
Frequently Asked Questions
What is clinical trial NCT06007404 about?
NCT06007404 is a clinical study titled "Understanding Metabolism and Inflammation Risks for Diabetes in Adolescents". This research study collects health-related information and blood samples to better understand how body composition, lifestyle habits, and diet influence meta-inflammatory monocytes (MiMos) in adolescents. The hypothesis of this study is that adolescents at risk for metabolic disease have enhanced M...
What is the current status of trial NCT06007404?
This trial is currently recruiting. The enrollment target is 175 participants. The study started on 2023-09-06. Estimated completion is 2027-09.
What conditions does trial NCT06007404 study?
This clinical trial studies the following conditions: Obesity, Type 2 Diabetes, Insulin Resistance, PreDiabetes, Metabolic Disease.
Who is sponsoring clinical trial NCT06007404?
This trial is sponsored by University of Michigan, which has 1,327 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06007404 being conducted?
This trial has 1 study location across Michigan. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Obesity
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
A Hip Flexion Feedback System for Exercise Monitoring in Individuals With Osteoarthritis and Obesity
RECRUITING · Phase 1
-
Metabolic Adaptations to Weight Loss With and Without Exercise
RECRUITING · NA
-
Testing an Integrated PTSD and Weight Management Intervention: A Hybrid Type 1 Trial
RECRUITING · NA
-
TIRzepatide for the Treatment of Obesity in Patients With Atrial Fibrillation
RECRUITING · Phase 2
-
Tirzepatide: Reversal of Lipotoxicity and Adipose Tissue Dysfunction in Humans With Overweight/Obesity
RECRUITING · Phase 2
-
Tai Chi as a Novel Strategy to Increase Physical Activity Among Adults Pursuing Metabolic and Bariatric Surgery
RECRUITING · NA
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.